Ray Dalio Pulmonx Corp Transaction History

Bridgewater Associates, LP

  • $19.6 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$15.35 - $23.99 $8,549 - $13,362
557 Added 1.07%
52,412 $873,000
Q2 2022

Aug 11, 2022
BUY
$14.0 - $27.95 $154,952 - $309,350
11,068 Added 27.14%
51,855 $763,000
Q1 2022

May 13, 2022
BUY
$21.13 - $35.65 $237,226 - $400,242
11,227 Added 37.98%
40,787 $1.01 Million
Q4 2021

Feb 14, 2022
SELL
$29.72 - $45.1 $53,258 - $80,819
-1,792 Reduced 5.72%
29,560 $948,000
Q3 2021

Nov 12, 2021
BUY
$35.98 - $44.48 $1.13 Million - $1.39 Million
31,352 New
31,352 $1.13 Million

Others Institutions Holding LUNG

# of Institutions
124
Shares Held
30.8M
Call Options Held
1.2K
Put Options Held
1.2K
View Full List

About Pulmonx Corp

LUNG Quotes by TradingView
  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email